Introduction
,HYALURONIC ACID (HA) is a major component of ~oviat fluid, and plays a central role in ~ rication within the knee joint cavity. HA lmrations have been used as a therapeutic mterv ~:' " ention in the treatment of osteoarthritis ~()A) [1] . For example, several studies have shown ~t intra-articular HA treatment of osteoarthritic knees reduces painful symptoms and improves Iomt moblhty [2] [3] [4] . HA has also been used to treat traumatic arthritis and OA in horses [5] [6] [7] [8] . Double-blinded studies that have compared HA with placebo in intra-articular injection in patients with OA [9] [10] [11] and compared HA with intra-articular injection of steroids [12, 13] have also shown some subjective benefit. Some of these studies have suggested that the effects of HA may be directed toward synovial tissue [14] . The subjective benefit of HA, regarding pain reduction, may be related to analgesic properties as suggested in an experimental animal model in which HA was shown to have an analgesic action on bradykinininduced pain in the knee joints of rats [15] with high molecular weight HA producing long-lasting and significant analgesis [16] . The exact mechanism of this apparent pain relieving action is uncertain.
The effects of HA have also been studied in cell culture and cartilage explant models of chondrocytic chondrolysis. HA has been shown to have anti-inflammatory effects, including inhibition of phagocytosis [17, 18] , inhibition of chemotaxis of inflammatory cells [19] , removal of free radicals and other reactive oxygen species [20] and inhibition of prostaglandin synthesis [21] . HA has also been shown to block proteoglycan (PG) release induced by interleukin-1 (IL-1) in rabbit articular chondrocytes in vitro [22] , to inhibit IL-1 induced PG degradation in bovine articular cartilage explants [23] , and to inhibit PG release from IL-1, tumour necrosis factor-~ (TNF-~) or basic fibroblast growth factor (b-FGF) treated bovine articular cartilage explants [24] . However, in one case, although PG loss from cartilage was blocked, the HA did not block cytokine-mediated protein synthesis suppression or matrix metalloproteinase (MMP) induction [22] . Therefore, more studies are required to ascertain mechanism(s) of action of HA in these culture models. The effect of HA in blocking damage in vivo has been studied in many different types of models of cartilage damage as described in the accompanying manuscript, part II.
We have used a well-characterized cartilage damage system to test the effects of a commercial preparation of HA and its mode of action. This system employs fragments of native fibronectin (Fn-f) which we have shown to cause cartilage chondrolysis in vitro [25] and in vivo [26] . These Fn-fs bind to and penetrate cartilage tissue [27] , resulting in greatly-enhanced levels of collagenase, gelatinases and stromelysin-1 (MMP-3) [25] , as well as suppression of PG synthesis [28] . These two activities cause up to 50% degradation and loss of the PG from cultured cartilage, resulting in essentially irreversible damage [28 30 ]. This rate of PG degradation and loss may be two to three orders of magnitude faster than experienced in arthritic diseases. A major MMP involved in this rapid PG degradation is MMP-3 [30] , and its induction, as well as the suppression of PG synthesis, appear to be mediated through Fn-f mediated release of TNF-~, IL-I~, IL-lfl and IL-6 [31] . The relevance of this model to human diseases is supported by the observations that elevated levels of Fn-fs are found in the synovial fluids of patients with OA and rheumatoid arthritis [32] , and that injection of Fn-fs into rabbit knee joints causes over 50% removal of knee joint articular cartilage PG within 7 days [261.
Since this Fn-f model involves extensive cartilage damage and physical penetration of the mediator into cartilage tissue, this model serves as an ideal test system for HA, which may establish a physical barrier on the superficial surface of cartilage. We have investigated the ability of 800-kDa HA to slow Fn-f mediated cartilage chondrolysis and to restore the PG content of Fn-f damaged cartilage tissue. The 800-kDa HA form was focused on in these studies because of reports of greater efficacy of higher mass forms [17 22] . In an accompanying manuscript, we report the effects of 800-kDa HA on blocking cartilage PG depletion in knee joint cartilage of rabbits injected with the Fn-f and the reparative properties in this in vivo model.
Materials and Methods

CHEMICALS AND REAGENTS
All common chemicals and reagents, as well as fetal bovine serum, were from Sigma Chemical Co. (St. Louis, MO, U.S.A.). HA of masses of 60, 250 and 800 kDa and 5-aminofiuoresceinated 800-kDa HA were provided by Seikagaku Corporation (Tokyo, Japan). The 800-kDa form is denoted HA/800 here. NHS-biotin and FITC-avidin were from Pierce Chemical Co. 
ISOLATION OF FN-FS
Fn-fs were generated from human Fn as described [29, 33] . The Fn-f tested was a wellcharacterized amino-terminal 29-kDa Fn-f, which has been found to be the most potent and is referred to as the Fn-f [25] .
EXPLANT CARTILAGE CULTURES
Culturing of slices of bovine articular cartilage was performed as described [25, [27] [28] [29] [30] in Dulbecco's modified Eagle's medium (DMEM) containing 50U/ml penicillin-streptomycin, with or without 10% fetal bovine serum, and with 50-80 mg cartilage per 2 ml/well. The native fibronectin was not removed from the serum because we have shown that it does not interfere with Fn-f mediated cartilage chondrolysis [25] . Three culture wells were treated identically in order to determine each mean and standard deviation value (S.D.). Each experiment was performed three times with bovine cartilage collected on 3 different days but cultured and tested identically. The data shown are the averages from a typical culture experiment. In testing of HA, the HA was added 24h before addition of the Fn-f.
PG-RELEASE FROM ORGAN CULTURES EXPOSED TO THE FN-F
Release of PG into the culture media was used as one index of cartilage damage. Kinetic constants for rates of PG release into the conditioned media were measured as described [25, 28] by assays of PG content of the conditioned media using the dimethylmethylene blue (DMB) dye-binding assay as described [25, 28] . Each experimental mean and S.D. were based on assays of three culture wells.
PG-CONTENT OF CARTILAGE
Decreases in PG content of articular cartilage during culture as mediated by Fn-f was used as a second index of cartilage damage and were measured as described [29] using the DMB assay on papain digests of cartilage. Each experimental mean and S.D. were based on assays of three culture wells. Error bars on figures correspond to S.D. values.
CHARACTERIZATION OF INTERACTION OF
5-AMINOFLUORESCEINATED HA/800 WITH CARTILAGE Cartilage was incubated with l mg/ml 5-aminofluoresceinated HA/800 (provided by Seikagaku Corporation, Tokyo, Japan) for 3 days in 10% serum/DMEM. The media were then changed to remove exogenous HA. Slices were removed at various times, extensively washed with DMEM and subjected to fluorescence microscopy as described above. Photography was performed using 1.5 min exposures.
WESTERN BLOT ANALYSIS OF MMP-3
A protein solution, typically obtained from conditioned media derived from 3-25 mg cartilage, was dialyzed and concentrated to 201tl and subjected to electrophoresis by the method of Laemmli [35] . Western blotting with MMP-3 anti-sera and autoradiography were performed as described [30] .
HISTOCHEMICAL CHARACTERIZATION OF CARTILAGE
TISSUE
Cartilage samples were fixed for 1 week in 10% neutral buffered formalin containing 5% cetylpyridinium chloride, dehydrated in ascending grades of ethanol and then embedded in paraffin. Microscopic sections (8 pro) of the samples were stained with hematoxylin and eosin and with toluidine blue [34] to demonstrate matrix PG.
MICROSCOPIC CHARACTERIZATION OF INTERACTION
OF BIOTINYLATED FN-F WITH CARTILAGE Solutions (2 ml) of 0.5 mg/ml Fn-f in 0.1 M sodium bicarbonate, pH 8.5, were reacted with NHS-biotin as described by Pierce Chemical Co. Cartilage was incubated with 1 mg/ml HA/800 in 10% serum/ DMEM with or without 100 nM biotinylated Fn-f. After 2 days, cartilage was recovered, subjected to cryosectioning (10pro) and slides exposed to 1 mg/ml avidin-rhodamine in 0.1 mg/ml bovine serum albumen in PBS. After 1 h, slides were incubated with PBS-albumin for 1 h and then washed with a slow stream of PBS-albumin (3 ml per section). Sections were then rinsed for 5 min in PBS and mounted in glycerol on cover slides. Slides were then visualized with an Olympus BH-2 microscope equipped with epifluorescence using appropriate filters for fluorescein. A ×10 objective and ×2 ocular were used to photograph, using 400 ASA Kodak Tri-X film pushed to 1600 ASA with 4 min per exposure.
RATES OF 3~S-SODIUM SULFATE INCORPORATION
35S-sulfate incorporation was used as an index of synthesis of sulfated PG. Rates were measured as described [28, 29] with six similar culture wells used to calculate means and S.D. values.
RESTORATION OF PG IN FN-F TREATED CARTILAGE
Cartilage tissue was cultured in 10 or 20% serum-DMEM and the Fn-f added to a 100 nM final concentration. Media were changed every other day. At 7 days, samples of cartilage were removed, cartilage digested with papain and total PG in the digest determined with the DMB assay to confirm that the PG content had decreased by about 50%. The media in some of the cultures containing 100 nm Fn-f were replaced with media containing only 10 or 20% serum-DMEM and 1 mg/ml HA/800. Media were changed every other day and PG assays of cartilage, after papain digestion performed at days 14, 21 and 28. Each experimental mean and S.D. were based on assays of at least three culture wells. Error bars on figures correspond to S.D. values.
Results
EFFECT OF HA/800 ON FN-F MEDIATED PG RELEASE
HA/800 did not decrease the rate of Fn-f mediated PG release into the culture media in serum free, conditions. Cartilage was cultured in serum-free insulin-like growth factor-1 (IGF-1)
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supplemented conditions (25 ng/ml) to test the ability of a continuous or 1 day pretreatment with HA/800 to block Fn-f mediated PG release into the media. A concentration of 0.1 or 1 mg/ml HA/800 did not significantly decrease the rates of PG release due to 100, 300 or 1000 nM Fn-f (data not shown).
EFFECT OF HA/800 IN LONG-TERM CULTURES HA/800 suppressed Fn-f mediated cartilage PG depletion in long-term 21 day cultures in 10% serum-DMEM. We next tested the effect of HA/800 in 10% serum where the rates of PG depletion are decreased several fold as compared with serum-free conditions [25, 28, 30] . This also allowed us to monitor the PG depletion over a longer period, of up to 21 days. Fig. 1 shows that a continuous incubation with either 0.1 or 1 mg/ml HA/800 protected against Fn-f mediated PG depletion maximally from days 0 to 7 with half the protection lost by about 12 days. By 14 days, most of the protection had been lost.
A single 1 day pretreatment of cartilage with HA/800 was effective in blocking Fn-f mediated Fro. 1. Test of effect of continuous incubation with 0.1 and 1 mg/ml HA/800 on blocking PG depletion by 100 nM Fn-f in long-term 21 day cultures in 10% serum-DMEMbovine articular cartilage slices (about 60 mg/well) were removed from bovine joints and added to 2 ml culture wells in 10% serum/DMEM. After a 2 day equilibration, the cultures were adjusted to 0.1 or 1 mg/ml HA/800. After another 24h, the media were removed and replaced with media containing HA/800 and with or without 100 nM Fn-f. Every other day media was changed to allow a continuous incubation with HA/800 and Fn-f. At days 7, 14, 21 cartilage was removed, subjected to papain digestion and total PG measured using the DMB assay. Curves correspond to control with nothing added (O); 100 nM Fn-f added at day 0 and included each day in culture (0); addition of HA/800 at day 0, followed by addition of Fn-f after 1 day and continuous culture in presence of both Fn-f and 0.1 mg/ml HA/800 (V) or Fn-f and 1 mg/ml HA/800 (V). cartilage PG depletion in long-term 21 day cultures in 10% serum-DMEM. We next tested whether a 1 day pretreatment of cartilage with HA/800 was as effective as continuous treatment over a 21 day period. We first tested the ability of a pretreatment with HA/800 to block action of 100nM Fn-f. Fig. 2(a) shows effects similar to those of the continuous incubations in Fig. 1 , except in the pretreatment conditions with 0.1 mg/ml HA/800, half of the protection was lost by 7 days instead of by 12 days as shown for continuous treatment. However, pretreatment with 1 mg/ml HA/800 for 1 day was as effective as a continuous incubation and suppressed PG depletion for 7 days. The amount of 4~rotection can be estimated based on our observation that 10 nM Fn-f does not cause PG depletion until 7 days (29; and below), which suggests that HA/800 has reduced the effectiveness of 100 nM Fn-f to that of 10 nM Fn-f and caused a 90% blocking effect.
The effect of a single 1 day pretreatment with 1 mg/ml HA/800 on blocking PG depletion by a lower concentration of the Fn-f, 10 nM, in 21 day cultures in 10% serum-DMEM was tested next. Fig. 2(c) shows that 10 nM Fn-f did not cause severe PG depletion until after day 14 and eventually caused 50% PG depletion by day 21. However, a single 1 day pretreatment with HA/800 afforded complete protection.
EFFECT OF SMALLER HA FORMS
HA of 60-kDa was ineffective in blocking Fn-f mediated PG depletion while 250-kDa was as effective as 800-kDa. Smaller HA forms were tested for comparison. Cartilage cultures were adjusted to i mg/ml 60 or 250-kDa HA and after 24 h, the media were adjusted to 0.1 #M Fn-f. Fig. 3 shows that after 5 days, the 60-kDa HA did not decrease Fn-f mediated PG depletion while the 250-kDa HA was as effective as HA/800 and blocked PG Fig.  1 and adjusted to 1 mg/ml of three different mass forms of HA. After another 24 h, the media was removed and replaced with media containing HA and with or without 100 nM Fn-f. Every other day media was changed to allow a continuous incubation with HA and Fn-£ At days 7, 14, 21 cartilage was removed and PG measured. Curves correspond to control with nothing added (O); 100 nM Fn-f added at day 0 and included each day in culture (Q); addition of 1 mg/ml 60-kDa HA (y), 250-kDa HA (V) or HA/800 (O). Culturing was continued in the presence of both Fn-f and HA. depletion for 14 days in culture. Thus, the protective effect of HA required a mass greater than 60-kDa. The HA/800 form remained the focus of subsequent studies.
MICROSCOPIC CHARACTERIZATION
Microscopic characterization of cartilage slices confirmed that HA/800 suppressed Fn-f mediated PG depletion. Staining with toluidine blue of PG in control, Fn-f treated and HA protected tissue at day 6 in culture confirmed the results of PG assays and showed that HA/800 had a protective effect. Control sections (Fig. 4(a) ] showed stain concentrated around the cells in the pericellular region and evenly distributed in the inter-territorial region between the cells. The superficial zone of cartilage, including the articular surface stained less well than the deeper regions of cartilage. However, sections from Fn-f treated cartilage [ Fig. 4(b) ] showed a diminished staining pattern. This pattern was first evident at day 2 in culture (data not shown). Visual examination suggested that cell numbers were unaffected by the Fn-f treatment. The articular surface appeared to be unaffected by Fn-f treatment. Sections from HA/800 protected cartilage [ Fig. 4(c) ] demonstrated normal PG staining and were virtually indistinguishable from control sections.
EFFECT OF VISCOSITY ON FN-F ACTIVITY
Dextran, which increased the viscosity of the culture media, did not suppress, the activity of the Fn-f. In order to test whether the viscosity increasing effect of HA/800 might explain the protective effect, dextran of 2 MDa was included in culture media at concentrations of 0.1, 1, 5 or 10 mg/ml in the presence of 0.1 gM Fn-f to increase the viscosity of the media. After 5 days of culture, the control tissue showed 34.9__ 3.1#g PG/mg cartilage, the Fn-f treated tissue showed 20.5 ± 2.3 and tissue co-treated with Fn-f and dextran at 0.1, 1, 5 or 10 mg/ml dextran showed PG contents of 19.3 ± 2.5, 18.9 + 1.9, 17.7 ± 2.4 and 19.9 ± 3.4 pg/ mg cartilage, respectively. Therefore, increasing the viscosity of the culture media was not sufficient for blocking the action of the Fn-f.
HA/800-SUPPRESSED PENETRATION OF
BIOTINYLATED FN-F INTO CARTILAGE TISSUE
We attempted to visualize microscopically the penetration of biotinylated Fn-f into tissue in the presence or absence of HA/800. HA/800 bound mostly to the superficial surface. Fig. 6(a) shows that when fluoresceinated HA/800 was added to cartilage for 3 days, it bound in a thick layer on the superficial surface with only very faint signal throughout the tissue. This surface binding may account for the physical blocking of penetration of the Fn-f. To test how long the HA/800 remained bound, the exogenous labeled HA was removed from the media, the culture media changed twice during the next 7 days and after an additional 7 days, the tissue analyzed. As shown in Fig. 6(b) , the fluorescence was of similar intensity as at 3 days, indicating that HA/800 still remained tightly bound to the articular surface. Note that when compared with the superficial surface, much less HA/800 bound to the lower cut surface near the calcified region, which was also freely accessible during the culture. with reduced release of MMP-3 and lesser suppression of PG synthesis. If the amount of Fn-f penetrating into the tissue had been reduced by HA/800, there should have been a reduction in the magnitude of two catabolic activities of the Fn-f, enhanced release of MMP-3 and suppression of PG synthesis. Fig. 7 shows by Western blot analysis of conditioned media, that use of both 0.1 or I mg/ml HA/800 led to a lower induction of MMP-3. The amount of M1VtP-3 in 0.1 or I mg/ml HA/800 treated culture media at day 7 in culture was only 35 and 21%, respectively, of that in cultures treated with Fn-f only, based on densitometric analysis of the bands. Therefore, the indirect effect of lmg/ml HA/800 was to suppress MMP-3 release fivefold. The size of the MMP-3 bands was 43-kDa which corresponds to active MMP-3 and not pro-MMP-3 of 55-kDa. Therefore, the release of (pro)MMP-3 was suppressed but not the activation of pro-MMP-3 to MMP-3. Table I shows that while 100 nm Fn-f suppressed PG synthesis by about 50% as also reported elsewhere, the presence of l mg/ml HA/800 caused a reversal of the suppression while 0.1mg/ml HA/800 did not have a significant effect.
LACK OF INTERACTION OF
FIG. 6. Visualization of interaction of 5-aminofluoresceinated 800-kDa HA with cartilage tissue. Bovine articular cartilage tissue in 10% serum-DMEM was cultured in the presence of 1 mg/ml fluorescein labeled HA/800 (provided by Seikagaku Corporation) for 3 days. The media was then removed and 10% serum-DMEM added back. Cartilage was removed after 3 and 10 days of culture and subjected to cryo-sectioning as described in Fig. 5 and fluorescence microscopy as described in Methods.
complex, the components were mixed in DMEM and 24h later, the mixture subjected to gel filtration on Sephacryl S-300 eluted with 100 mM sodium phosphate, 150 mM NaC1, pH 7.4. The yield and elution positions were compared with that of the same quantity of Fn-f alone. The Fn-f mixed with HA/800 eluted at the position expected for non-complexed Fn-f and the area of the peak was similar to that observed with Fn-f alone (data not shown). Therefore, interaction of HA/800 with Fn-f had not occurred under these conditions.
EFFECT ON MMP-3 AND PG SYNTHESIS
The effect of HA/800 on suppression of Fn-f mediated cartilage PG depletion was associated FIG. 7. Effect of HA/800 on blocking Fn-f mediated enhanced release of MMP-3--conditioned media from cultures prepared as in Fig. 1 were reduced and subjected to electrophoresis on 10% Laemmli SDS gels as described [30] . The gels were blotted and the blots reacted with rabbit anti-human pro-MMP-3 anti-sera and 12SI-labeled protein G for autoradiography as described [30] . Shown are size standards in lane S; 2 pg of human pro-MMP-3 in lane 1, media from Fn-f treated cultures in lane 2; media from Fn-f and I mg/ml HA/800 treated cultures in lane 3; media from Fn-f and 0.1 mg/ml HA/800 treated cultures in lane 4. Control 100 + 16 100 nM Fn-f 53 ± 8 0.1 mg/ml HA 109 i 9 1.0 mg/ml HA 109 ± 8 100 nM Fn-f+ 0.1 mg/ml HA 55 ± 5(ns):~ 100 nM Fn-f+ 1.0 mg/ml HA 92 ± 7(s)$ *Cartilage in 10% serum/DMEM was incubated with 0.1 mg/ml HA/800 or with 100 nM Fn-f or with 0.1 mg/ml HA/800 and Fn-f for 24 h followed by adjustment of cuP, ures to 10 pCi/m135S sodium sulfate. Labeling was allowed to continue for 2 h, followed by washing of the cartilage and extraction of cartilage with 4 M GuHC1, 20 mM EDTA, 0.1 M sodium acetate, pH 5.0. The extracts were exhaustively dialyzed and subjected to scintillation counting.
tThe value shown are percent of incorporation for control cartilage and values of standard deviation (S.D.). P values were based on Student's t-test where a value of less than 0.05 was considered significant. Number of samples was 6.
:~ns (not significant); s (significant). Based on comparison with 100 nM Fn-f data.
HA/800 P R O M O T E D P A R T I A L R E S T O R A T I O N O F P G I N FN-F T R E A T E D C A R T I L A G E
Because HA/800 blocked Fn-f mediated PG depletion, we considered that it had potential for repairing Fn-f damaged cartilage. Cartilage was first damaged by t r e a t m e n t with Fn-f in 10 or 20% s e r u m -D M E M and then treated with 1 mg/ml HA/800 without Fn-f. Conditions of 20% serum, which would contain higher concentrations of anabolic factors, were tested to determine if repair could be optimized. Fig. 8 shows t h a t repair did not occur in the presence of 10 (a) or 20% (b) serum alone. Linear regression analysis showed that the slopes for these control curves from days 7-21, in 10% serum (a) or in 20% serum (b), were not significantly greater than zero. However, HA/800 increased the respective slope from 0 to 0.174 _+ 0.0248 (r2=0.96) in 10% serum [ Fig. 8(a) ]; this slope was significantly greater t h a n zero ( P = 0.02). Fig. 8(b) shows that there was a lower amount of initial PG depletion in 20% serum as compared with 10% serum, however HA/800 increased the slope from 0 to 0.189+_0.041
(r 2= 0.91), but with a lower degree of significance (P= 0.04). We conclude that HA/800 did promote significant repair in vitro of Fn-f treated and damaged cartilage.
Discussion
HA/800 did not block Fn-f mediated PG release in serum-free conditions, likely because the rate of degradation is too great. Serum-free conditions allow a decrease in PG content by 90% within 3 days [25, 27] . Therefore, cultures were established in 10% serum, which would contain high concentrations of serum proteinase inhibitors. We have shown that addition of serum-derived proteinase inhibitors to conditioned media does slow Fn-f mediated damage [30] and that conditions of 10% serum slows the rate of PG depletion such that half the total PG is lost within 7 days [29] . Under the 10% serum conditions, continuous incubation with either 0.1 or 1 mg/ml HA/800 slowed the half-time for 100 nM Fn-f mediated PG depletion from 3 to 15 days. Based on the half-time for PG depletion, HA/800 decreased the effectiveness of 100 nM to that of 10 nM Fn-f, a quite significant effect. Histologic analysis of HA/800 protected tissue confirmed that PG depletion was blocked.
A single pre-treatment with 1 mg/ml HA/800 for 1 day, followed by its removal, was as effective as a continuous incubation in blocking 100 nM Fn-f, although in the case of 0.1mg/ml HA/800, continuous treatment was necessary for maximal blocking activity. Further, as we decreased the test concentration of Fn-f from 100 to 10 nM Fn-f and again tested a single treatment with 1 mg/ml HA/800, total blocking activity was observed over a 26 day period. Because the media were changed up to 13 times during the tests of pretreatment, these data are consistent with the observation that fluoresceinated HA/800, when added to media at 1 mg/ml, did not perceptively dissociate from cartilage when it was used to briefly pre-treat cartilage.
HA forms of 60-kDa were ineffective in blocking PG depletion, while a 250-kDa form was as effective as HA/800, suggesting that the protective effect required a minimal molecular weight. The blocking action of HA/800 did not occur simply by enhancing the viscosity of the culture media and thus, slowing diffusion of the Fn-f into cartilage. This was shown by the inability of dextran to block PG depletion. The protective effect of HA/800 was not likely due to it complexing tightly with the Fn-f because a complex could not be visualized after mixing the components in DMEM and subjecting the mixtures to gel filtration in 100 mM sodium phosphate, 150 mM NaC1, pH 7.4. However, it is possible that interaction might occur in the presence of 10% serum/DMEM as used in the cultures.
The most likely explanation for the mechanism of action of HA/800 is that it blocked penetration of the Fn-f into tissue. Microscopy of cartilage cultured with labeled Fn-f showed that HA/800 greatly decreased Fn-f binding on the superficial surface, diffusion throughout the matrix and the intense localization around cell clusters. Parallel studies with fluorescently labeled HA/800 showed that HA/800 bound to the superficial surface without penetrating deeply. Because the N-terminal 29-kDa Fn-f used here can bind heparinoid compounds [36] , the HA/800 may have bound PG near the surface and decreased binding and subsequent penetration of the Fn-f. Others have proposed that HA may act by slowing penetration of macromolecules by enhancing viscosity near the articular surface [37] , although our tests using dextran showed that altering the viscosity of the bulk media did not block the action of the Fn-f. Whatever the mechanism for HA-800 binding to the surface, it should be noted that our data showed that HA/800 bound mostly to the superficial surface of cultured cartilage, although the basal cut surface was also accessible, and the binding appeared to be of high affinity because HA/800 was still present after several changes of culture media.
Because it was conceivable that HA/800 may have decreased cartilage PG depletion simply by blocking effusion of degraded PG out of the cartilage, we investigated whether HA blocked two of the major causative events involved in Fn-f mediated PG depletion, enhanced expression of MMP-3 and suppression of PG synthesis. The data indicated that 1 mg/ml HA greatly decreased both activities, while 0.1 mg/ml HA was ineffective or much less effective, consistent with measurements of PG loss. It should be noted that others have reported that HA of about 250-kDa suppresses PG synthesis while HA of much higher mass did not [38] . While we did not test HA/250 for PG synthesis suppression, it was as effective as HA/800 in terms of blocking PG depletion. If it does suppress PG synthesis, this may suggest that this effect did not contribute to a decrease in steady state levels of PG as measured here during the time course of the culture. Nonetheless, HA/800 did block the effect of the Fn-f but by itself had no effect on PG synthesis in the absence of the Fn-f.
Because HA has been suggested to repair cartilage in patients with OA ]9-11] and in various animal models of cartilage damage, as discussed in the accompanying manuscript, this activity was tested in vitro and found to be significant. This activity could not result from the ability of HA/800 to block penetration of the Fn-f into the cartilage because the Fn-f had already been removed from the culture. It is conceivable that HA/800 bound to catabolic mediators released into the media, thereby blocking their re-entry into the tissue and effectively decreasing their concentrations. However, a more likely explanation might be that HA acted as an anti-oxidant because it is known to inactivate reactive oxygen species [20] , and reactive oxygen species are known to be released from chondrocytes in the presence of IL-1 and TNF-~ and to mediate cytokine activities [39, 40] . This explanation is plausible because we have shown that the Fn-f operate through catabolic cytokines [31] , that the action of the cytokines can be blocked with anti-oxidants [41] and that anti-oxidants promote restoration of PG in Fn-f treated tissue [42] . If cytokine action is prolonged after the Fn-f is removed from damaged cartilage, [ which we have shown to be the case (Homandberg et al., unpublished observations)], the HA, as an anti-oxidant, may block prolonged cytokine action long enough to allow restoration of PG.
In summary, HA/800 slowed the Fn-f mediated cartilage chondrolysis by binding to the superficial surface of cartilage slices and greatly decreasing penetration of Fn-f into cartilage tissue and the resultant catabolic activities of the Fn-f, enhanced release of MMP-3 and suppression of PG synthesis. HA/800 also enhanced restoration of PG in Fn-f damaged cartilage, perhaps through its anti-oxidant activity. The relevance of the work presented here is strengthened by our work in a companion manuscript in which we report that HA/800 also decreased knee cartilage PG depletion when injected with Fn-f into rabbit knee joints and also exhibited reparative properties.
